Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Deutsche Medizinische Wochenschrift (1946)
|
May 3, 2002
[Do we need new ways of cell and gene treatment of diabetics? - Contra]
H J Lüddeke
International Journal of Clinical Practice. Supplement
|
April 3, 2003
Postprandial hyperglycaemia--its importance and implications
H J Lüddeke
Fortschritte Der Medizin
|
January 16, 1999
[Continuing education provided by the Diabetes Society. Results of the UKPDS (United Kingdom Diabetes Society) and therapeutic guidelines concerning diabetes type II]
H J Lüddeke
International Journal of Clinical Practice. Supplement
|
November 7, 2000
Improving post-prandial control with Humalog and Humalog mixtures
H J Lüddeke
Der Internist
|
March 1, 1990
[Possibilities and risks of insulin pump therapy]
R Renner, H J Lüddeke
MMW Fortschritte Der Medizin
|
June 29, 2000
[Insulin resistance. Frequently administration errors are the source]
T Rendschmidt, H J Lüddeke, R Renner, et al.
Diabetes, Obesity & Metabolism
|
March 30, 2007
Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine: clinical practice experience from a German subgroup of the PREDICTIVE study
L F Meneghini, K H Rosenberg, C Koenen, et al.
Diabetes, Obesity & Metabolism
|
November 24, 2007
Transferring to insulin detemir from NPH insulin or insulin glargine in type 2 diabetes patients on basal-only therapy with oral antidiabetic drugs improves glycaemic control and reduces weight gain and risk of hypoglycaemia: 14-week follow-up data from PREDICTIVE
A Dornhorst, H-J Lüddeke, C Koenen, et al.
International Journal of Clinical Practice
|
March 8, 2008
Insulin detemir improves glycaemic control without weight gain in insulin-naïve patients with type 2 diabetes: subgroup analysis from the PREDICTIVE study
A Dornhorst, H-J Lüddeke, S Sreenan, et al.
International Journal of Clinical Practice
|
February 23, 2007
Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohort
A Dornhorst, H-J Lüddeke, S Sreenan, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Deutsche Medizinische Wochenschrift (1946)
|
May 3, 2002
[Do we need new ways of cell and gene treatment of diabetics? - Contra]
H J Lüddeke
International Journal of Clinical Practice. Supplement
|
April 3, 2003
Postprandial hyperglycaemia--its importance and implications
H J Lüddeke
Fortschritte Der Medizin
|
January 16, 1999
[Continuing education provided by the Diabetes Society. Results of the UKPDS (United Kingdom Diabetes Society) and therapeutic guidelines concerning diabetes type II]
H J Lüddeke
International Journal of Clinical Practice. Supplement
|
November 7, 2000
Improving post-prandial control with Humalog and Humalog mixtures
H J Lüddeke
Der Internist
|
March 1, 1990
[Possibilities and risks of insulin pump therapy]
R Renner, H J Lüddeke
MMW Fortschritte Der Medizin
|
June 29, 2000
[Insulin resistance. Frequently administration errors are the source]
T Rendschmidt, H J Lüddeke, R Renner, et al.
Diabetes, Obesity & Metabolism
|
March 30, 2007
Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine: clinical practice experience from a German subgroup of the PREDICTIVE study
L F Meneghini, K H Rosenberg, C Koenen, et al.
Diabetes, Obesity & Metabolism
|
November 24, 2007
Transferring to insulin detemir from NPH insulin or insulin glargine in type 2 diabetes patients on basal-only therapy with oral antidiabetic drugs improves glycaemic control and reduces weight gain and risk of hypoglycaemia: 14-week follow-up data from PREDICTIVE
A Dornhorst, H-J Lüddeke, C Koenen, et al.
International Journal of Clinical Practice
|
March 8, 2008
Insulin detemir improves glycaemic control without weight gain in insulin-naïve patients with type 2 diabetes: subgroup analysis from the PREDICTIVE study
A Dornhorst, H-J Lüddeke, S Sreenan, et al.
International Journal of Clinical Practice
|
February 23, 2007
Safety and efficacy of insulin detemir in clinical practice: 14-week follow-up data from type 1 and type 2 diabetes patients in the PREDICTIVE European cohort
A Dornhorst, H-J Lüddeke, S Sreenan, et al.
Page
of 2